Board of Directors The Board of Directors is responsible for the overall management and supervision of the Siegfried Holding AG: It appoints the CEO and the members of the Executive Committee and defines and supervises the strategic goals of the company.
From left: Wolfram Carius, Martin Schmid, Alexandra Brand, Andreas Casutt, Isabelle Welton, Colin Bond, Beat Walti
Board Independence Statement In accordance with the Siegfried Group Board Regulations, the Chairman of the Board of Directors, the Chairman of the Audit Committee as well as the majority of the members of the Board of Directors must be non-executive and independent. In line with the Swiss Code of Best Practice, the members of the Board of Directors are considered non-executive and independent if they (i) are currently not members of the Executive Committee and have not belonged to the Executive Committee in the last three years, and (ii) have no or only relatively minor business relations with Siegfried.
For the composition of its Board of Directors, Siegfried aims to achieve and maintain an appropriate balance of skills and knowledge, taking into account the core and adjacent business fields of the pharmaceutical industry in which Siegfried is active, its international orientation, the accounting and legal requirements of listed companies, as well as the growing need for Board level expertise in the fields of compensation, digitalization and sustainability. A diverse Board with different views improves decision-making and ensures sustainable decision-making and long-term success in the interest of all our stakeholders.
Hence, the Board of Directors considers and values a variety of individual criteria of its members, including industry experience, experience in executive and management functions, knowledge in finance and accounting, governance, compliance and law, expertise in ESG and information technology, as well as gender and other diversity criteria. In accordance with the Diversity, Inclusion and Equality Policy of the Siegfried Group, Siegfried strives to achieve a gender diversity with women representing no less than 30% of its Board members.
The Board regularly conducts a self-assessment of the performance of its members as well as its processes and organization, with the target to improve the governance, enhance efficacy, identify gaps in the skill sets and diversity and define future priorities.
Current Board Composition The Board of Directors of Siegfried Holding AG currently consists of seven non-executive members from four different countries. Two of the seven members of the Board of Directors are female (quota of 29%). All members of the Board of Directors of the current term of office 2022/2023 qualify as non-executive and independent within the meaning of the Swiss Code of Best Practice for Corporate Governance. None of the current members ever held a position in the Executive Committee of Siegfried or any other company of the Siegfried Group, nor did they, or the companies or organizations they represent, ever have any significant business relationship with Siegfried.
Andreas Cassut Chairman
Andreas Cassut Chairman
Andreas Casutt Chairman
Andreas Casutt, Ph.D., Chairman, Siegfried Holding AG Andreas Casutt (1963) joined the Board of Siegfried Holding AG in 2010 and was elected Chairman in 2014. He has been a partner of the law firm Niederer Kraft Frey AG in Zurich since 2002, and held office as managing partner from 2006 to 2014. Andreas Casutt specializes in Corporate law, Contract law, Mergers & Acquisitions, and Stock Exchange law. In addition, he is a board member of Mikron Holding AG, maxon international AG, Liechtenstein-based Bendura Bank AG and various privately held companies.
Andreas Casutt studied law and received his Ph.D. in Zurich and completed an LL.M. program at the University of Michigan, Ann Arbor. Andreas Casutt is a Swiss citizen.
Colin Bond, Member of the Board of Directors, Siegfried Holding AG
Colin Bond (1961) joined the Board of Siegfried Holding AG in 2013. He has been Chief Financial Officer of Sandoz AG since May 2022. Previously Colin Bond held positions as Chief Financial Officer of Vifor Pharma AG and of Evotec AG. Following career stations as a pharmacist, chartered accountant and management consultant, he worked for 25 years as Chief Financial Officer for several international companies in various industries, of which 11 years for Great Lakes Chemical Corporation, today Lanxess, a US-based global specialty chemicals company. He is a board member at BioPharma Credit PLC.
Colin Bond holds a university degree in pharmacy from the University of Aston, Birmingham, and a MBA degree from London Business School.
He is a citizen of Great Britian and Switzerland.
Dr. Alexandra Brand, Member of the Board of Directors, Siegfried Holding AG
Alexandra Brand (1971) joined the Board of Siegfried Holding AG in 2022. She has been holding various senior management positions with Syngenta since 2015. In 2021, she was appointed Regional Director for EAME Crop Protection. In prior functions, she served as Syngenta’s Chief Sustainability Officer and as Regional Director, Europe, Africa & Middle East. Prior to joining Syngenta, Alexandra Brand held various positions with increasing importance and responsibility with BASF for more than 15 years. In 2019, Alexandra Brand was elected to the board of directors of Azelis, a PE-owned leading global distributor of specialty chemicals and food ingredients. Alexandra Brand studied Chemistry at the University of Darmstadt, where she also received her Ph.D. in inorganic chemistry in 1998.
Alexandra Brand is a German citizen.
Wolfram Carius, Ph.D., Member of the Board of Directors, Siegfried Holding AG
Wolfram Carius (1961) joined the Board of Siegfried Holding AG in 2014. In October 2020 he was appointed Executive Vice President Pharmaceuticals heading the newly created Cell and Genetherapy unit at Bayer. Since September 2016, he served as Executive Vice President Pharmaceuticals Product Supply at Bayer and member of the Executive Committee at Bayer Pharma. Previously, Wolfram Carius worked for Sanofi, a French healthcare company, as Senior Vice President Biopharma Biologics and member of the Global Leadership Team. From 1987 to 2013, Wolfram Carius held various positions with the pharma company Boehringer Ingelheim. In 2009, he was appointed to the company’s Board of Managing Directors, initially with responsibility for Human Resources and Technical Operations, and from 2012 for Biopharma and Operations. Before that, he was responsible for the development and expansion of the biopharma unit. He managed the company’s production site in Japan and worked later in Brazil as technical director before being appointed member of Boehringer Ingelheim’s Board of Managing Directors in Germany. Wolfram Carius serves at the board of the privately held Uhlmann Group in Germany as well as on the boards of Südpack Medica AG and Ferring Ventures in Switzerland.
Wolfram Carius holds a Ph.D. in Pharmaceutical Biology and Analytical Phytochemistry from the University of Saarland, Germany. In 2009, the Biberach University of Applied Sciences awarded him the title of honorary professor in recognition of his long and exceptional service.
Wolfram Carius is a German citizen.
Martin Schmid, Ph.D., Member of the Board of Directors, Siegfried Holding AG
Martin Schmid (1969) has been a member of the Board of Directors of Siegfried Holding AG since 2016. He was elected State Councillor of the Canton of Graubünden in 2011. From 2003 to 2011 he was a member of the government of the Canton of Graubünden, where he headed the Department of Justice, Security and Health and subsequently the Department of Finance. Martin Schmid is an attorney-at-law. He is a member of the Board of Directors of Swiss Life Holding AG, Repower AG and holds various other directorships in the energy and construction sectors. He also chairs the Swiss Gas Industry Association (VSG ASIG), the Swiss Development Association, the Graubünden Cantonal Hospital Foundation and the Institute of Finance and Financial Law at the University of St. Gallen (IFF-HSG). He is also a member of the board of economiesuisse. He studied law at the University of St. Gallen, where he received his doctorate in 2005.
Martin Schmid is a Swiss citizen.
Dr. Beat Walti, Member of the Board of Directors, Siegfried Holding AG
Beat Walti (1968) joined the Board of Siegfried Holding AG in 2022. He has been a partner of Wenger Vieli, a Zurich-based law firm since 2007, specializing in matters of commercial and corporate law and governance issues. From 1999 to 2013, Beat Walti was a member of the Cantonal Council of Zürich. In 2014, Beat Walti became member to the Swiss National Council, where he belongs to the Economic Affairs and Taxation Committee and also presided over the parliamentary group of “FDP/the liberals” from 2017 – 2022. Beat Walti chairs the Foundation Board of the Ernst Göhner Foundation. He is a member of the board of DSV A/S in Denmark and holds various positions as chairman or member of the board of privately held companies and foundations. In addition, Beat Walti is chairman of the board of OSPITA (Association of Swiss Enterprises in the Healtcare Sector) and member of the board of the Commercial Chamber of the Canton of Zürich and the advisory board of ExpertSuisse, the Swiss expert association for audit, tax and fiduciary.
Beat Walti studied law at the Universities of Neuchâtel and Zurich and received his Ph.D. in 1998.
Beat Walti is a Swiss a citizen.
Isabelle Welton, Member of the Board of Directors, Siegfried Holding AG
Isabelle Welton (1963) was elected to the Board of Siegfried Holding AG in 2020. Isabelle Welton started her career with Citibank in Tokyo and subsequently changed to IBM, where she held various positions in marketing and communications before being appointed country general manager of IBM in Switzerland. In 2013, Isabelle Welton joined Zurich Insurance Group as member of the Group Executive Board with responsibility for Human Resources & Corporate Culture. Today, she is the owner of a consulting company focusing on corporate culture and change processes. Isabelle Welton serves on the boards of NZZ Media Group, the Avobis Group and the Swiss Institute of International Studies as well as on the foundation boards of Swisscontact, SOS Children’s Village Switzerland and the Lucerne Festival.